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ABSTRACT: Neurogenesis is the process of neuron
generation, which occurs not only during embryonic
development but also in restricted niches postnatally. One
such region is called the subventricular zone (SVZ), which
gives rise to new neurons in the olfactory bulb (OB). Neu-
rons that are born postnatally migrate through more
complex territories and integrate into fully functional cir-
cuits. Therefore, differences in the differentiation of
embryonic and postnatally born neurons may exist.
Dendritogenesis is an important process for the proper
formation of future neuronal circuits. Dendritogenesis in
embryonic neurons cultured in vitro was shown to depend
on the mammalian target of rapamycin (mTOR). Still
unknown, however, is whether mTOR could regulate the
dendritic arbor morphology of SVZ-derived postnatal OB
neurons under physiological conditions in vivo. The pres-
ent study used in vitro cultured and differentiated SVZ-
derived neural progenitors and found that both mTOR
complex 1 and mTOR complex 2 were required for the
dendritogenesis of SVZ-derived neurons. Furthermore,
using a combination of in vivo electroporation of neural
stem cells in the SVZ and genetic and pharmacological
inhibition of mTOR, it was found that mTOR was
crucial for the growth of basal and apical dendrites in
postnatally born OB neurons under physiological condi-
tions and contributed to the stabilization of their basal
dendrites. VC 2016 The Authors Developmental Neurobiology Published
by Wiley Periodicals, Inc. Develop Neurobiol 00: 000–000, 2016
Keywords: postnatal neurogenesis; mTOR; dendritogen-
esis; olfactory bulb; in vivo electroporation
INTRODUCTION
Neurogenesis is a process of neuron generation
(Ming and Song, 2011), which occurs mainly during
Correspondence to: J. Jaworski (jaworski@iimcb.gov.pl).
Contract grant sponsor: ERA-NET-NEURON/03/2010 (co-
financed by the National Centre for Research and Development)
and National Science Centre grants; contract grant number: 2013/
08/T/NZ3/01013 (to AS), 2011/03/B/NZ3/01970 (to JJ) and 2013/
11/D/NZ3/01079 (to EL).
Agnieszka Skalecka and Ewa Liszewska have contributed
equally to this work.
Additional Supporting Information may be found in the online
version of this article.
This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs License, which
permits use and distribution in any medium, provided the original
work is properly cited, the use is non-commercial and no modifica-
tions or adaptations are made.
 2016 The Authors Developmental Neurobiology Published by
Wiley Periodicals, Inc.
Published online 00 Month 2016 in Wiley Online Library
(wileyonlinelibrary.com).
DOI 10.1002/dneu.22392
1
early embryonic development and in restricted form
also occurs postnatally, including in adulthood (G€otz
and Huttner, 2005; Paridaen and Huttner, 2014). One
postnatal neurogenic region is the subventricular
zone (SVZ), from where neural progenitors migrate
along the rostral migratory stream (RMS) toward the
olfactory bulb (OB) where they differentiate into neu-
rons (Carlen et al., 2002; Lledo et al., 2008) that
are involved in OB-dependent forms of plasticity
(Nissant et al., 2009). Neurogenesis includes neuron
birth, migration, differentiation, maturation, and inte-
gration. Many molecular mechanisms that underlie
neuronal development are shared in the embryonic
and postnatal periods (Urban and Guillemot, 2014).
However, neurons that are born postnatally need to
migrate through more complex territories and inte-
grate into fully functional circuits (Petreanu and
Alvarez-Buylla, 2002). Although substantial progress
has been made in understanding postnatal neurogene-
sis and subsequent neuron maturation, several ques-
tions remain unanswered. For example, the precise
molecular mechanisms that regulate newborn neuron
differentiation, maturation, and integration into pre-
existing circuits are still not fully known. Moreover,
the existence of important differences between
embryonic and postnatal neurogenesis have only just
begun to be revealed (Ming and Song, 2011; Urban
and Guillemot, 2014).
An important step of neuron maturation is dendri-
togenesis. The shape of the dendritic arbor reflects
the function of a neuron within a particular neuronal
circuit. Thus, its proper development is key for accu-
rate connectivity and synaptic organization within
any given neuronal ensemble (McAllister, 2000;
Wong and Ghosh, 2002; Urbanska et al., 2008). The
development of dendritic trees is a complex process
that requires tight molecular regulation and depends
on both the genetic program and various local envi-
ronmental cues. Among the intrinsic factors that reg-
ulate the dendritogenesis of postnatally born neurons
is the transcription factor cyclic adenosine mono-
phosphate response element-binding protein (CREB;
Giachino et al., 2005). Examples of extrinsic cues
include c-aminobutyric acid (GABA) and vascular
endothelial growth factor (VEGF) (Gascon et al.,
2006; Licht et al., 2010). However, considering the
numerous factors that regulate the dendritic arbor
development of embryonic neurons, the molecular
aspects of postnatally born OB neuron dendritogene-
sis have only been sparsely investigated. mTOR is a
large (259 kDa) serine/threonine kinase. In mamma-
lian cells, mTOR forms two distinct protein com-
plexes, mTORC1 and mTORC2, which are defined
by the presence of unique mTOR protein partners
(i.e., regulatory-associated protein of mTOR [Raptor,
mTORC1] and rapamycin-insensitive companion of
mTOR [Rictor, mTORC2]; Kim et al., 2002; Jacinto
et al., 2004; Malik et al., 2013; Sarbassov et al.,
2004). In addition to differences in protein composi-
tion, these two complexes differ in their substrates,
cellular localization, function, and sensitivity to the
mTOR inhibitor rapamycin (Malik et al., 2013).
Studies of in vitro cultured neurons showed that
mTOR plays important roles in neuronal develop-
ment, including dendritogenesis (Jaworski et al.,
2005; Kumar et al., 2005; Swiech et al., 2008; Urban-
ska et al., 2012a). In vivo studies are less numerous
(Thomanetz et al., 2013). However, work from the
Bordey group using a conditional knockout of TSC1
(Tuberous Sclerosis Complex 1), a well-known
mTORC1 inhibitor, in neural stem cells (NSCs) post-
natally in SVZ, shows that mTOR hyperactivity
results in dendritic arbor hypertrophy (Feliciano
et al., 2012). Similarly, hyperactivation of mTOR in
adult born neurons in dentate gyrus, due to loss of
Disc1, leads to excessive dendritic branching (Kim
et al., 2009; Zhou et al., 2013). Importantly, the role
of mTOR in SVZ-derived neurons under physiologi-
cal conditions has not been studied in vivo. Chemical
screening performed by Khodosevich and Monyer
(2010) questioned the importance of mTOR activity
for neurite formation by RMS-derived neuroblasts
cultured in vitro. This raises the question of whether
mTOR can regulate the dendritic arbor morphology
of SVZ-derived GABAergic postnatal OB neurons
under physiological conditions.
In the present study, we tested whether mTOR con-
tributes to regulating the dendritic arbor formation of
OB neurons that are generated early postnatally. Using
in vitro cultured and differentiated SVZ-derived neu-
roprecursors, we found that both mTORC1 and
mTORC2 are required for the dendritogenesis of SVZ-
derived neurons. Furthermore, using a combination of
in vivo electroporation of NSCs in the SVZ and
genetic and pharmacological inhibition of mTOR, we
found that mTOR is crucial for the growth of basal
and apical dendrites of postnatally born OB neurons
under physiological conditions, and it contributes to
the stabilization of their basal dendrites.
METHODS
Drugs and Antibodies
The following inhibitors were purchased from commercial
sources: rapamycin (LC Laboratories, Woburn, MA) and
Ku-0063794 (Chemdea, Ridgewood, NJ). Primary
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antibodies are listed in Table 1. Secondary anti-rabbit and
anti-mouse antibodies conjugated to horseradish peroxidase
(HRP; Jackson ImmunoResearch, West Grove, PA; 1:10,000)
were used for Western blot. Donkey anti-rabbit and anti-
mouse and goat anti-chicken secondary antibodies conju-
gated to Alexa Fluor dyes (Invitrogen, Eugene, OR) were
used for immunofluorescence both in cultured cells (1:300)
and brain sections (1:500).
DNA Constructs
The following mammalian expression plasmids, described
previously, were obtained from Addgene or directly from
other researchers: pCx-EGFP-N1 (Boutin et al., 2008),
pCAG-GFP (Matsuda and Cepko, 2004), pCALNL-DsRED
(Matsuda and Cepko, 2007), pCAG-Cre (Matsuda and
Cepko, 2007), pSUPER (Brummelkamp et al., 2002),
pSUPER-shRaptor#1 (Urbanska et al., 2012a), pSUPER-
shRictor#2 (Urbanska et al., 2012a), pSUPER-scrRaptor#1
(Urbanska et al., 2012a), pSUPER-scrRictor#2 (Urbanska
et al., 2012a), and pSUPER-mTOR7513 (Jaworski et al.,
2005). The empty vector pCAG was obtained by excising
the Cre coding sequence from pCAG-Cre with EcoRI/NotI.
Animals Used for the Studies
To prepare primary in vitro cultures of neural progenitors,
Wistar rat (Rattus norvegicus) pups (postnatal day [P] 1 or 2)
were used. The animals were sacrificed by decapitation
according a procedure approved by the First Local Ethics
Table 1 List of Primary Antibodies Used
No. Antigen Catalog No. Host
Application
and Dilution Vendor
1 GFAP AB5804 Rabbit IF 1:1000
(tissue culture)
Millipore
2 GFP 13970 Chicken IF 1:1000
(brain sections)
Abcam
3 GFP 598 Rabbit IF 1:1000
(tissue culture)
MBL
4 GFP NB100-1770 Goat IF 1:500
(tissue culture)
Novus Biologicals
5 Lectin FITC 128K1065 Mouse IF 1:300
(tissue culture)
Sigma-Aldrich
6 MAP2 M4403 Mouse IF 1:300
(tissue culture)
Sigma-Aldrich
7 MAP2 4542 Rabbit IF 1:1000
(tissue culture)
Cell Signaling
Technology
8 mTOR (7c10) 2983 Rabbit WB 1:500 Cell Signaling
Technology
9 Nestin Ab6142 Mouse IF 1:300
(tissue culture)
Abcam
10 NeuN ab104225 Mouse IF 1:1000
(tissue culture)
Abcam
11 Oligodendrocytes (RIP) MAB158 Mouse IF 1:300
(tissue culture)
Millipore
12 P-S6 (Ser235/236) 4858 Rabbit IF 1:300
(tissue culture);
WB 1:500
Cell Signaling
Technology
13 P-S6 (Ser240/Ser244) 5364 Rabbit IF 1:500
(brain sections)
Cell Signaling
Technology
14 S6 2217 Rabbit WB 1:500 Cell Signaling
Technology
15 P-Akt (Ser473) 4060 Rabbit WB 1:1000
IF 1:300
Cell Signaling
Technology
16 Akt 2920 Mouse WB 1:1000 Cell Signaling
Technology
17 Tuj 1 (neuron-specific
class III b-tubulin)
ab18207 Mouse IF 1:500
(tissue culture)
Abcam
18 a-tubulin T5168 Mouse WB 1:5000 Sigma-Aldrich
IF, immunofluorescence; WB, Western blot.
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Committee in Warsaw (decision no. 987/2009), which is in
compliance with the European Community Council Direc-
tive (86/609/EEC). For in vivo electroporation, wildtype
(C57BL/6 strain) P1 or P2 mice or Mtorfl/fl mice (on a
C57BL/6 background; Gangloff et al., 2004) were used in
accordance with procedures approved by the First Local
Ethics Committee in Warsaw (Decisions 189/2011), which
are in compliance with the European Community Council
Directive (86/609/EEC). All of the procedures that were
performed at McGill University were in compliance with
the Canadian Council on Animal Care guidelines and
approved by McGill University.
Primary In Vitro Culture of Neural
Progenitors and Neurons
Primary neural progenitor cultures were prepared from rat
neonates 24 h after birth (P1) according to the protocol
adapted from Giachino et al. (2009). A single rat pup (P1)
was decapitated, the brain was removed and placed into
cold Hank’s balanced salt solution (HBSS). The meninges,
OBs [Supporting Information Fig. 1(A), line #1], and cere-
bellum [Supporting Information Fig. 1(A), line #2] were
removed. The brain was cut coronally, approximately in the
middle [Supporting Information Fig. 1(A), line #3]. The
Figure 1 mTOR activity is necessary for proper dendritic arborization of SVZ-derived neurons
cultured in vitro. (A) Representative confocal images of SVZ-derived neurons immunofluorescently
stained for MAP2 and ribosomal protein S6 phosphorylated at Ser235/236 (P-S6). Scale bar5 25
mm. Two days after plating, brain-derived neurotrophic factor (BDNF; 50 ng/mL) and DMSO or
mTOR inhibitors (Ku-0063794 [KU], 30 nM; rapamycin [rapa], 20 nM) were added to the culture
medium. Four days after plating, the cells were fixed and immunostained. (B) Quantitative analysis
of average intensity of P-S6 immunofluorescence of neurons treated as in A. Number of experi-
ments (N)5 3. Number of analyzed cells (n)5 24 (control), 31 (KU), 32 (rapa), and 26 (BDNF).
The data are expressed as mean values normalized to the control. Error bars indicate SEM.
***p< 0.001; ns, not significant (Kruskal–Wallis test with Dunn’s post hoc test). AU, arbitrary
units. (C) Representative confocal images of neurons treated as indicated in A and immunofluores-
cently labeled with an antibody against MAP2. Scale bar5 25 mm. (D) Quantitative analysis of
number of dendrites based on MAP2 immunostaining of cells treated as in A. The bar graph shows
the analysis of the number of dendritic tips as a percentage of the value normalized to the BDNF
untreated control in a given experiment. Error bars indicate SEM. Number of experiments (N)5 3.
Number of analyzed cells (n)5 123 (control), 72 (KU), 69 (rapa), 105 (control1BDNF), 53
(KU1BDNF), and 72 (rapa1BDNF). ***p< 0.001, **p< 0.01 (Kruskal–Wallis test with Dunn’s
post hoc test).
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SVZ was microdissected [Supporting Information Fig. 1(A),
red dotted line], and the tissue was minced. The minced tissue
was incubated for 30 min at 378C with Papain mix composed
of 30 U/mL papain (Sigma-Aldrich, St. Louis, MO),
0.24 mg/mL cysteine (Sigma-Aldrich), 40 mg/mL DNAseI
Type IV (Sigma-Aldrich) and Ovomucoid mix: 1 mg/mL
trypsin inhibitor (Sigma-Aldrich), 0.5 mg/mL BSA (Sigma-
Aldrich), 40 mg/mL DNAse I Type IV (Sigma-Aldrich) in
HBSS in the ratio 1:1. The enzymatic reaction was stopped
by the addition of an equal volume of Ovomucoid mix fol-
lowed by an additional 5–10 min incubation at room tempera-
ture. Next, the tissue was dissociated using a 1 mL filter tip.
The obtained cell suspension was washed by adding and
resuspending the dissociated tissue in 9 mL Dulbecco’s Modi-
fied Eagle Medium (DMEM)/F12. The cells from the debris
were separated by centrifugation 5 min at 100g. The superna-
tant was discarded and the cell pellet was resuspended in pro-
liferation medium that contained DMEM/F12 with GlutaMax
supplement (Invitrogen, Carlsbad, CA), 2% B27 (Invitrogen),
20 nM recombinant epidermal growth factor (EGF; Alomone
Laboratories, Jerusalem, Israel), 20 nM recombinant basic
fibroblast growth factor (bFGF; Alomone Laboratories), and
1% penicillin/streptomycin mixture (Sigma-Aldrich) and
plated as a single-cell suspension on an uncoated plastic dish.
Neural progenitors were cultured as free-floating neuro-
spheres. The first passage was performed 5 days post-
isolation. The neurospheres were centrifuged at 100g for 5
min, resuspended in prewarmed 0.05% trypsin-EDTA
(Sigma-Aldrich) in HBSS and incubated at 378C for 10
min. Next, an equal volume of Ovomucoid mix was added
and the neurosphere suspension was incubated for an addi-
tional 5 min at room temperature. Then the neurospheres
were dissociated to a single cell using a 1 mL filter tip. The
obtained cell suspension was washed by adding 9 mL
DMEM/F12 and was centrifuged at 100g for 5 min. The
supernatant was then discarded, and proliferation medium
was added to the cell pellet. The cells were reseeded at a
density of 1 3 104 cells/cm2 in proliferation medium and
incubated at 378C with 5% CO2 until the next passage.
Neural progenitors were cultured as neurospheres for three
to four passages before differentiation.
For the differentiation of neural progenitors to neurons,
the neurospheres were first trypsinized and plated in neuron
growth medium that contained Neurobasal medium (Invitro-
gen), 2% B27 (Invitrogen), 0.5 mM glutamine (Sigma-
Aldrich), 12.5 mM glutamate (Sigma-Aldrich), 1% penicil-
lin/streptomycin mixture (Sigma-Aldrich) at a density of 500
cells/mm2 on glass coverslips coated with poly-L-ornithine
(15 mg/mL, Sigma-Aldrich), and laminin (5 mg/mL, Roche,
Basel, Switzerland). Differentiating neural progenitors were
kept in an incubator under standard culture conditions.
Transfection and Drug Treatment
of Differentiating SVZ-Derived Neural
Progenitors
After three to four passages, the neural progenitors were
first plated under differentiating conditions. The next day,
they were transfected with Lipofectamine2000 as described
previously for hippocampal neurons cultured in vitro
(Jaworski et al., 2009). To accelerate dendritogenesis and
activate mTOR signaling on day 2 after plating, differenti-
ating neural progenitors were treated with brain-derived
neurotrophic factor (BDNF; 50 ng/mL, Sigma Aldrich). To
inhibit mTOR activity, either rapamycin (20 nM) or Ku-
0063794 (30 nM) were added to the culture medium alone
or in combination with BDNF 48 h post-plating.
In Vivo Electroporation
and Pharmacological Treatment
The protocol and electroporation parameters were adapted
from Boutin et al. (2008). Neonates (C57BL/6, P1/P2)
were anesthetized on an ice-filled glass petri dish for
approximately 5 min. Subsequently, the animals were
placed on a custom-made support in a stereotaxic rig
under a Hamilton syringe with a manually pulled glass
capillary (<50 lm diameter). The DNA (3 lg/lL) for
electroporation was diluted in phosphate-buffered saline
(PBS)-I (147 mM NaCl, 2.7 mM KCl, and 20 mM phos-
phate buffer [pH 7.4]) that contained 0.1% Fast Green.
The syringe filled with the DNA solution was positioned
at the level of the right lateral ventricle [Supporting Infor-
mation Fig. 2(A)] and introduced 2 mm deep into the
lumen. An injection was considered correct when Fast
Green dye was visible under white light in the lateral ven-
tricle. Successfully injected animals were subjected to
five poring electrical pulses (50 ms, 95 V, pulses at 950
ms intervals) followed by five transfer pulses (50 ms, 20
V, pulses at 50 ms intervals) using a CUY21 device
(Nepagene, Chiba, Japan) and 10 mm tweezer electrodes
(CUY650P10, Nepagene). The tweezer electrodes were
oriented to target plasmid DNA to the dorsal wall of the
ventricles [Supporting Information Fig. 2(A)]. Afterward,
electroporated animals were warmed on a heating pad for
several minutes and returned to their dams. To inhibit
mTOR activity, electroporated pups were treated with
rapamycin. Rapamycin treatment was adapted from
Anderl et al. (2011). Rapamycin was initially dissolved in
100% ethanol at a concentration of 0.1 mg/mL and stored
at 2208C. Immediately before the injection, rapamycin
was diluted in a sterile vehicle solution that contained
0.25% Tween 80 and 0.25% PEG 400 (low-molecular-
weight grade of polyethylene glycol). Mouse neonates
were intraperitoneally (IP) injected with either two or
three doses of 1 mg/kg rapamycin beginning on P8 or
P10, respectively. The doses were administered at 48 h
intervals. A control group received ethanol in vehicle
solution.
Immunofluorescent Staining
of In Vitro Cultured Cells
For immunofluorescence staining, cells that were cultured
on glass coverslips were fixed with 4% paraformaldehyde
(PFA) and 4% sucrose in PBS-II (135 mM NaCl, 2.7 mM
mTOR Regulates Dendritogenesis in Olfactory Bulb 5
Developmental Neurobiology
KCl, 4.3 mM Na2HPO4, and 1.4 mM KH2PO4; pH 7.4) for
10 min at room temperature. After fixation, the cells were
washed three times for 10 min each with PBS-II and incu-
bated with primary antibodies diluted in GDB (30 mM
phosphate buffer [pH 7.4], 0.2% gelatin, 0.5% Triton X-
100, and 450 mM NaCl) overnight at 48C. The next day,
the cells were washed three times for 10 min each with
PBS-II and incubated for 1 h with appropriate Alexa Fluor-
conjugated secondary antibodies diluted in GDB at room
temperature, followed by three washes for 10 min each
with PBS-II. During the second wash, Hoechst 33258
(1:10,000; Invitrogen) was added. In the last step, each cov-
erslip was rinsed with purified, sterile water and closed
with VECTASHIELD mounting medium (Vector Laborato-
ries, Burlingame, CA) on a glass slide.
Immunofluorescent Staining of Mouse
Brain Sections
The mice were deeply anesthetized with an overdose of
pentobarbital (300 mg/kg body weight, IP) and transcar-
dially perfused with PBS-I followed by 4% PFA in 0.1M
phosphate buffer (pH 7.4). Brains were isolated and post-
fixed for 2 h in 4% PFA in 0.1M phosphate buffer (pH 7.4).
Postfixed brains were cryopreserved with 30% sucrose in
0.1M phosphate buffer for at least 72 h. Afterward, the
brains were frozen and cut into 40 or 100 lm thick sections
on a cryostat and collected in antifreeze medium. Immuno-
fluorescence was performed on free-floating sagittal or cor-
onal brain sections. Prior to immunostaining, the brain
sections were washed three times for 5 min each with
Figure 2.
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PBS-I. For 100-mm thick sections, an additional step was
included in the procedure. Specifically, PBS-I was replaced
with an antigen retrieval buffer (10 mM Trisodium citrate,
0.05% Tween 20), and the sections were incubated for an
additional 15 min at 608C. Next, the brain sections were
washed three times for 5 min each with PBS-I. Both 100
and 40 lm brain sections were next incubated for 1 h at
room temperature with blocking buffer (PBS-I that con-
tained either 1% donkey or normal goat serum and 1% or
0.2% Triton-X 100 for 100 and 40 lm thick brain sections,
respectively). The brain slices were then incubated over-
night at 48C with primary antibodies in an appropriate
blocking buffer. After this overnight incubation, the sec-
tions were washed three times with PBS-I and incubated at
room temperature for 1 or 2 h, depending on the section
thickness, with fluorochrome-conjugated secondary anti-
bodies diluted in an appropriate blocking buffer. In the next
step, the slices were rinsed three times with PBS-I for 5
min each. Hoechst 33258 was added (1:10,000) to the sec-
ond PBS-I wash. Stained brain slices were mounted on
microscope slides, dried for 15 min at room temperature,
and then closed under glass coverslips using VECTA-
SHIELD mounting medium.
Preparation of Brain Protein Extracts
The brains were removed immediately after decapitation.
The OBs were dissected, frozen on dry ice, and stored at
2808C until use. The brain tissue was homogenized in
homogenization buffer, followed by centrifugation at maxi-
mum speed (12,000g) for 15 min. Next, the supernatants
were collected, and protein concentrations were measured
using the BCA Protein Assay Kit (Thermo Fisher
Figure 2 Proper dendritic arborization of SVZ-derived neurons cultured in vitro requires both
mTORC1 and mTORC2. (A) Representative confocal images of SVZ-derived neurons transfected
as indicated and immunofluorescently stained for ribosomal protein S6 phosphorylated at Ser235/
236 (P-S6) and GFP. Scale bar5 5 mm. Neural progenitors were isolated from the SVZ, dissoci-
ated, and plated in differentiation-promoting conditions. On day 1, the cells were transfected with
pSUPER (control), pSUPER-mTOR7513 (shmTOR), pSUPER-shRaptor#1 (shRaptor#1),
pSUPER-shRictor#2 (shRictor#2) or pSUPER-shRaptor#1 and pSUPER-shRictor#2 (shRaptor#1/
shRictor#2). A GFP-encoding plasmid was co-transfected in all of the variants to visualize neuron
morphology. Brain-derived neurotrophic factor (BDNF) was added 24 h postransfection. Cells
were fixed 4 days after plating. (B) Quantitative analysis of average intensity of P-S6 immunofluo-
rescence of neurons transfected and treated as in A. Number of experiments (N)5 2. Number of
analyzed cells (n)5 59 (pSUPER, control), 37 (shmTOR), 44 (shRaptor#1), 38 (shRictor#2), 44
(shRaptor#1/shRictor#2). The data are expressed as mean values normalized to the control. Error
bars indicate SEM. ***p< 0.001; ns, not significant vs. control (Kruskal–Wallis test with Dunn’s
post hoc test). AU, arbitrary units. (C) Representative confocal images of SVZ-derived neurons
transfected and treated as in A and stained for Akt phosphorylated at Ser473 (P-Akt) and GFP.
Scale bar5 5 mm. Progenitors were isolated from the SVZ, dissociated, and plated in
differentiation-promoting conditions with brain-derived neurotrophic factor (BDNF). On day 1
cells were transfected as in A. (D) Quantitative analysis of average intensity of P-Akt immunofluo-
rescence of neurons treated as in A. Number of experiments (N)5 2. Number of analyzed cells
(n)5 31 (pSUPER, control), 28 (shmTOR), 31 (shRaptor#1), 35 (shRictor#2), 31 (shRaptor#1/
shRictor#2). The data are expressed as mean values normalized to the control. Error bars indicate
SEM. ***p< 0.001; ns, not significant vs. control; ###p< 0.001 vs. shRaptor#1 (Kruskal–Wallis
test with Dunn’s post hoc test). AU, arbitrary units. (E) Representative confocal images of SVZ-
derived neurons transfected as indicated and immunofluorescently stained for GFP. Scale bar5 20
mm. Progenitors were isolated from the SVZ, dissociated, and plated in differentiation-promoting
conditions. On day 1, the cells were transfected with pSUPER (control), pSUPER-mTOR7513
(shmTOR), pSUPER-shRaptor#1 (shRaptor#1), pSUPER-shRictor#2 (shRictor#2), pSUPER-
shRaptor#1 and pSUPER-shRictor#2 (shRaptor#1/shRictor#2), pSUPER-scrRaptor#1 (scrRap-
tor#1) or pSUPER-scrRictor#2 (scrRictor#2). A GFP-encoding plasmid was co-transfected in all of
the variants to visualize neuron morphology. BDNF was added 24 h postransfection. Cells were
fixed 4 days after plating. (F) Quantitative analysis of the number of dendrites of neurons trans-
fected and treated as in E. The bar graph shows the analysis of the number of dendritic tips as a per-
centage of the value normalized to the control in a given experiment. Error bars indicate SEM.
Number of experiments (N)5 3. Number of analyzed cells (n)5 34 (pSUPER), 52 (shmTOR), 48
(shRaptor#1), 57 (shRictor#2), 56 (shRaptor#1; shRictor#2), 30 (scrRaptor#1), 30 (scrRictor#2).
***p< 0.001, ns - not significant vs. control, ###p< 0.001 vs. shRaptor#1, $$$p< 0.001 vs. shRic-
tor#2 (Kruskal–Wallis test with Dunn’s post hoc test).
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Scientific, Waltham, MA). Afterward, the proteins were
denaturated in Laemmli buffer by heating at 958C for 10
min. Protein extracts were then analyzed using standard
Western blot techniques.
Image Acquisition and Analysis
Non-confocal images of immunofluorescently labeled cells
in culture were collected using a fluorescence microscope
(Nikon Eclipse 80i) equipped with a 203 objective, digital
camera (Media Cybernetics, Silver Spring, MD), and Image-
Pro Plus software (Media Cybernetics, Silver Spring, MD).
Confocal images of immunofluorescently labeled in vitro
cultured cells were collected using a Zeiss LSM 710NLO
microscope and 203 dry objective. Images were collected at
1024 3 1024 pixel resolution as a series of z-sections, each
averaged twice per line. The obtained stack was flattened
into a single image using maximum intensity projections.
For all of the experiments that involved fluorescence inten-
sity analysis, the acquisition settings were kept constant for
all of the experimental variants. The fluorescence intensity
of P-S6 or P-Akt immunostained culture neurons was meas-
ured using the native region measurement function of the
Fiji software package. Neuronal somata were first freehand-
traced based on green fluorescent protein (GFP) expression.
The intensity of the analyzed immunofluorescence at an
appropriate emission wavelength was then measured.
Confocal images of immunolabeled brain sections were
collected using a Zeiss LSM 710 NLO microscope with
103 and 203 dry objectives or 403 and 633 oil objec-
tives, depending on the analyzed parameter. Images were
acquired at a 1024 3 1024 pixel resolution as a set of
z-sections at either 4 or 1.2 mm intervals, depending on the
type of analysis. For all of the experiments that involved
fluorescence intensity analysis, the acquisition settings
were kept constant for all of the experimental variants. For
initial processing of the collected pictures, Zen 2010 soft-
ware (Zeiss, Jena, Germany) was used.
Morphometric Analysis
For the morphometric analysis of in vitro cultured SVZ-
derived neurons, each z-stack was flattened into a single
image using the maximum intensity projection function of
ZEN2010 software. To quantitatively describe changes in
dendritic arbors, the total number of dendritic tips (TNDT)
was analyzed. The analysis of TNDT of SVZ-derived neu-
rons was performed manually using the cell counter module
of the Fiji software package.
The morphometric analysis of dendritic arbors and cell
volume of neurons in vivo was performed using images that
were acquired from 100-mm thick brain slices. Three differ-
ent square fields of view were taken for each slice. For den-
dritic arbor analysis, each image was a z-stack of 10–20
images, depending on the neuron’s location in the brain
slice and slice thickness. For data analysis, only micro-
scopic images with sufficient GFP expression and a good
signal-to-noise ratio were included. Images of cells with
incomplete dendritic arbors were excluded from the analy-
sis. To quantitatively describe changes in dendritic arbors
of neurons in vivo, neural arbors were first manually traced
on a three-dimensional reconstruction of collected images
using Simple Neurite Tracer software, Fiji (Longair et al.,
2011). On these traces, we analyzed TNDT, total dendrite
length (TDL; sum of all dendrite lengths), and dendrite
density distribution as a function of distance from the neu-
ron cell soma (Sholl analysis; Sholl, 1953). The analyses
were performed separately for apical and basal dendrites.
To measure neuron cell soma volume, 100-mm thick brain
slices were used. For the analysis, three different square
fields of view were taken for each slice. Each image was a
z-stack of five images. Neuron soma volume was measured
using Imaris software (Bitplane, Zurich, Switzerland).
Z-stack images with visible GFP-positive cells were
uploaded to Imaris software, and the cell body volume was
obtained using its native Surface mode function.
Statistical Analysis
For the in vitro culture experiments, data were collected
from at least two independent primary cultures. For each
experimental condition, images of cells from two coverslips
were collected. The results are presented as the arithmetic
mean6 standard error of the mean (SEM) and analyzed for
statistically significant changes using the Kruskal–Wallis
test and Dunn’s post hoc test using Prism 5.03 software
(GraphPad, San Diego, CA).
To analyze the results of the in vivo experiments, we used
one of the following statistical tests, depending on the param-
eter under study: Mann–Whitney test, one-way analysis of
variance (ANOVA), or two-way repeated-measures ANOVA
with appropriate within- and between-subjects factors. For
the Mann–Whitney test and ANOVA, Prism 5.03 software
and SPSS 21 software (IBM) were used, respectively.
RESULTS
mTOR Activity is Necessary for
Dendritogenesis of SVZ-Derived Neurons
In Vitro
mTOR plays an important role in regulating the den-
dritogenesis of embryonic neurons cultured in vitro.
The question that arises, however, is whether mTOR
is also needed for the dendritogenesis of postnatally
born neurons (e.g., in the SVZ). To answer this ques-
tion prior to laborious in vivo experimentation, we
used primary tissue cultures of postnatal neural pro-
genitors that were obtained from the SVZ and cul-
tured under differentiating conditions. As shown in
Supporting Information Figure 1(B), cells that were
obtained from dissociated neurospheres and plated
under differentiation conditions differentiated mainly
into neurons (MAP2-immunopositive cells) and
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astrocytes (GFAP-immunopositive cells) after 4 days
in culture. Cells that were positive for lectin and
receptor interacting protein (RIP) were also present
[Supporting Information Fig. 1(B)], suggesting that
our preparations contained microglia and oligoden-
drocytes. Additional immunofluorescent staining for
two independent neuronal markers (neuron-specific
b-tubulin isotype III [Tuj1] and anti-NeuN) con-
firmed that neural progenitors became neurons after 4
days in culture [Supporting Information Fig. 1(C)].
Cells that are derived from the SVZ are known to dif-
ferentiate mainly into axonless, GABAergic granule
neurons. MAP2-positive cells stained negative for
Tau-1, an axonal marker (not shown).
Since our major aim was to study the development
of dendritic arbors, we first established the precise
timing of this process in our preparations. Depending
on the neuron type and in vitro culture conditions,
particular phases of development, including dendrito-
genesis, may occur with different timing. To this end,
progenitors were cultured under defined differentia-
tion conditions for 4 days. Each day, the cells were
immunofluorescently labeled for nestin (neural pro-
genitor marker) and MAP2 (mature neuron marker).
MAP2 staining was additionally used to assess den-
dritic arbor morphology. As shown in Supporting
Information Figure 1(D), on day 0 (day of cell plat-
ing) most of the cells that stained positive for nestin,
were negative for MAP2. Over the following days,
the number of nestin-positive neural progenitors pro-
gressively declined and disappeared completely by
the third day. Conversely, the number of MAP2-
positive cells began to increase on day 1. With regard
to the development of proper morphology, progeni-
tors began to grow neurites just a few hours after
plating. On day 1, structures that resembled growth
cones were clearly visible at the tip of the principal
processes [Supporting Information Fig. 1(D)]. Cell
protrusions progressively differentiated into den-
drites, with numerous filopodia [Supporting Informa-
tion Fig. 1(D)] from the second day onward. During
the first 2 days in vitro, dendrites grew mainly in
length. From the third day onward, the cells began to
form secondary dendrites and develop more complex
dendritic arbors, which were established by day 4
[Supporting Information Fig. 1(D)].
Having established the time course of dendritogen-
esis of SVZ-derived neurons, we proceeded to study
the role of mTOR during this process. We began the
analysis using pharmacological inhibitors of mTOR.
Two inhibitors of mTOR with different mechanisms
of action were used, rapamycin and Ku-0063794. We
first tested whether both inhibitors effectively inhibit
mTOR in our preparations at concentrations
described previously (Jaworski et al., 2005; Urbanska
et al., 2012a). Neural progenitor cells that were
derived from the SVZ were first differentiated into
neurons for 2 days, and then mTOR inhibitors were
added to the culture for the next 48 h. Afterward, the
cells were immunostained for MAP2 and the ribo-
somal protein S6 phosphorylated on serines 235/236
(P-S6), a positive indicator of mTORC1 activity. As
a positive control, cells were treated with BDNF (50
ng/mL), a known inducer of mTORC1 activity (Takei
et al., 2004). As shown in Figure 1(A,B), the P-S6
immunofluorescence intensity significantly decreased
with both mTOR inhibitors, confirming their efficacy
under the tested culture conditions. BDNF slightly
but nonsignificantly increased P-S6 immunofluores-
cence intensity compared with the control. Next, we
tested the effects of the inhibitors on dendritic arbori-
zation under basal culture conditions adding them as
described above. Additionally, we asked question
whether BDNF, which was able to activate mTOR,
can induce mTOR-dependent increase in dendritic tree
arborization of SVZ-derived neurons. Although there
were no previous reports on positive effects of BDNF
on dendritogenesis of SVZ-derived neurons cultured
in vitro we decided to use this trophic factor because
it has been shown previously in vivo to be critical
for proper dendritic arbor development of different
classes of neurons, including those present in the OB
(Berghuis et al., 2006). In the case of BDNF treatment,
the trophic factor was added with DMSO (as a control)
or the inhibitor after 2 days in culture for another 48 h.
Next, the cells were immunofluorescently labeled for
MAP2, and the number of MAP2-positive processes
was counted [Fig. 1(C,D)]. Both rapamycin and Ku-
0063794 significantly reduced the number of den-
drites, as previously described for embryonic hippo-
campal neurons cultured in vitro (Jaworski et al.,
2005; Kumar et al., 2005; Urbanska et al., 2012a). The
2-day treatment with BDNF caused a robust increase
in the number of MAP2-positive protrusions. In con-
trast, the application of either mTOR inhibitor signifi-
cantly diminished the pro-growth effect of BDNF
[Fig. 1(C,D)]. Thus, we concluded that mTOR activity
is needed for the proper arborization of SVZ-derived
neurons cultured in vitro, both under basal conditions
and upon BDNF treatment.
mTORC1 and mTORC2 are Needed for
Dendritogenesis of SVZ-Derived Neurons
In Vitro
The data presented above point to an important
role for BDNF and mTOR in the dendritic arbor
development of postnatally born SVZ-derived
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neurons. However, both long-term rapamycin treat-
ment (>4 h; Urbanska et al., 2012a) and Ku-006379
(allosteric inhibitor) blocked the activity of both
mTOR complexes. Thus, our observations did not
indicate which mTOR complex is involved in the
regulation of SVZ-derived neuron dendritogenesis
upon BDNF treatment. To dissect the differential
contributions of mTORC1 and mTORC2 to this pro-
cess, we took advantage of plasmids that encoded
shRNAs against Raptor and Rictor, which have been
thoroughly characterized in our laboratory previously
on hippocampal neurons (Urbanska et al., 2012a).
First however, we decided to test if those shRNAs
affect signaling downstream mTORC1 and mTORC2
Figure 3.
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in the SVZ-derived preparations the same way as in
hippocampal ones. The plasmids that encoded spe-
cific shRNAs against Raptor and Rictor were trans-
fected to SVZ-derived neurons individually or as a
mix 1 day after plating. Transfection of the plasmid
that encoded mTOR shRNA served as a positive con-
trol, and the empty vector pSUPER was used as a
negative control, which was previously described to
be indistinguishable from several tested scrambled
shRNAs (Urbanska et al., 2012a). In all of the var-
iants, a plasmid that encoded GFP was added to the
transfection mixtures to help identify transfected
cells. The next day after transfection (day 2 after
plating), BDNF was added to the culture medium
to enhance activation of both mTORCs. Two days
later (day 4 after plating), the cells were fixed and
immunofluorescently labeled for P-S6 and P-Akt
(serine 473), which served as indicators of
mTORC1 and mTORC2 activity, respectively.
Knockdown of Raptor affected level of P-S6 but
not P-Akt, whereas knockdown of Rictor affected
both P-S6 and P-Akt [Fig. 2(A–D)], as previously
shown for hippocampal neurons (Urbanska et al.,
2012a). mTOR shRNA as well as mix of Raptor
and Rictor shRNAs decreased levels of both P-S6
and P-Akt. This suggests that in SVZ-derived neu-
rons similar to hippocampal ones, mTORC2 may
act upstream of mTORC1. We also noted that
mTOR shRNA decreased P-S6 and P-Akt IF levels
less efficiently than shRaptor and shRictor, respec-
tively. Fact that it was also less potent than mix of
Raptor and Rictor shRNAs indicates that shmTOR
had relatively mild efficiency. This is consistent
with results obtained previously with use of this
mTOR shRNA (Jaworski et al., 2005).
In the next series of experiments, SVZ-derived
neurons were transfected and treated with BDNF, as
described above, but instead of signaling pathway
analysis we counted the total number of dendritic tips
(TNDT) of transfected neurons based on GFP fluores-
cence [Fig. 2(E,F)]. As shown in Figure 2, transfection
with mTOR shRNA reduced TNDT compared with
pSUPER-transfected cells. The knockdown of either
Raptor or Rictor or both also effectively blocked den-
dritic arborization [Fig. 2(E,F)]. In contrast, overex-
pression of scrambled sequences of shRNAs against
Raptor (scrRaptor#1) or Rictor (scrRictor#2) did not
affect BDNF-induced dendritic arborization [Fig.
2(E,F)]. Thus, we concluded that in the case of cul-
tured in vitro postnatally born neurons derived from
SVZ, similarly to embryonic hippocampal neurons,
both mTORCs are indispensible for extracellular
factor-induced dendritogenesis. This result encouraged
us to further study this process in vivo.
Figure 3 Overexpression of Cre recombinase in neural stem cells in Mtorfl/fl mice leads to
mTORC1 inhibition in RMS neuroblasts and mature neurons in the OB. (A) Diagram illustrating
genomic changes in cells of Mtorfl/fl mice electroporated with pCAG-CRE encoding Cre recombi-
nase. (B) principle of Cre-dependent expression of DsRed in electroporated cells. (C) Representa-
tive confocal images of OB in Mtorfl/fl mice electroporated with pCAG-GFP, pCALNL-DsRed, and
pCAG (control) or pCAG-GFP, pCALNL-DsRed, and pCAG-Cre (experimental variant) on P1 and
sacrificed at 14 dpe. Olfactory bulb sections were immunostained for GFP (green). DsRed was
visualized solely by its fluorescence (red). Brain sections were additionally counterstained with
Hoechst 33258 (Hoechst; blue). Scale bar5 100 mm. (D) Representative confocal images of migrat-
ing neuroblasts. Mice were electroporated as in C at the age of P1 and sacrificed at 5 dpe. Brain
sections were immunostained for GFP (green) and the phosphorylated form of the ribosomal pro-
tein S6 (P-S6, Ser 240/244) (magenta). DsRed was visualized solely by its fluorescence (red).
White lines outline cell bodies that were positive for GFP/DsRed or GFP. Brain sections were addi-
tionally counterstained with Hoechst 33258 (Hoechst; blue) to visualize nuclei. Scale bar5 5 mm.
(E) Representative confocal images of neurons in the olfactory bulb. Mice were electroporated as
described in C and sacrificed at 14 dpe. Olfactory bulb sections were immunostained for GFP
(green) and P-S6 (magenta). DsRed was visualized solely by its fluorescence (red). All of the OB
sections were additionally counterstained with Hoechst 33258 (Hoechst; blue) to visualize nuclei.
White lines outline cell bodies that were positive for GFP/DsRed or GFP. Scale bar5 5 mm.
(F) Quantitative analysis of neuroblast cell soma volume in mice electroporated as in C, presented
as a mean value6 SEM. Number of animals (N)5 2 per group. Number of analyzed cells (n)5 20
(control), 20 (Cre). *p< 0.05 (Mann–Whitney test). (G) Quantitative analysis of OB neuron
cell soma volume in mice electroporated as in C, presented as a mean value6SEM. Number of
animals (N)5 2 per group. Number of analyzed cells (n)5 20 (control), 20 (Cre). ***p< 0.001
(Mann–Whitney test).
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mTOR Knockout Reduces the
Complexity of Dendritic Arbors of
Postnatally Born OB Granular Neurons
To determine the involvement of mTOR in the den-
dritogenesis of SVZ-born neurons that mature in the
OB, we took advantage of the postnatal in vivo elec-
troporation of neural stem cells that reside in the
SVZ. We focused on the SVZ-RMS-OB system
because the role of mTOR in the physiological den-
dritic arbor development of postnatally born OB neu-
rons has not been previously demonstrated. Previous
studies suggested that the hyperactivation of mTOR
in this cells caused by knockout of TSC1 leads to the
aberrant dendritic growth of OB neurons (Feliciano
et al., 2012). To selectively decrease mTOR activity
in postnatally born neurons, neonatal (P1-P2) Mtorfl/fl
mice were co-electroporated with a mixture of
pCAG-Cre, pCALNL-DsRed and pCAG-GFP (exper-
imental variant), or pCAG (empty vector), pCALNL-
DsRed and pCAG-GFP (control variant) [Fig. 3(A)].
pCAG-Cre encodes constitutively expressed Cre
recombinase, and pCALNL-DsRed causes DsRed
expression only in cells that express Cre, serving as a
positive marker of recombination [Fig. 3(B)]. Elec-
troporated Mtorfl/fl mice were sacrificed on either 5 or
14 days post-electroporation (dpe), and cryostat brain
sections were immunostained for GFP and P-S6. In
control animals, electroporated cells in the RMS (5
dpe) and OB (14 dpe) stained positively for GFP
[Fig. 3(C–E)] and were negative for DsRed expres-
sion. In animals from experimental variant (Cre) the
expression of inducible DsRed was already visible in
GFP-positive RMS neuroblasts at 5 dpe [Fig. 3(D)].
At 14 dpe, approximately 40% of GFP-positive neu-
rons in the mouse OBs was DsRed-positive [Fig.
3(E)]. The analysis of mTOR activity using P-S6
immunofluorescence revealed lower level of P-S6 in
GFP- and DsRed-positive neuroblasts at 5 dpe and
OB neurons at 14 dpe compared with controls [Fig.
3(D,E)]. In addition to examining P-S6 immunofluo-
rescence, the cell volume of electroporated cells was
measured as a known morphological hallmark of
mTOR pathway inhibition in developing neurons. As
shown in Figure 3(G), the cell volume of Cre-
expressing DsRed-positive OB neurons decreased by
30% compared with controls. Unexpectedly, migrat-
ing neuroblasts lacking mTOR presented significant
increase of the volume of cell soma [Fig. 3(F)]. This
cell body swelling may represent a first hallmark of a
cell death, as in some animals sacrificed at 14 dpe we
observed less GFP-positive cells in the OB of Cre-
electroporated mice than in control plasmid electro-
porated ones (not shown).
Next, we repeated the experiment described above
but this time focused on analyzing the effect of
mTOR knockout on dendritic trees of OB neurons 14
dpe using three-dimensional reconstructions of GFP-
positive cells [Fig. 4(A,B)]. Newly born neurons in
the OB bear several short basal dendrites and one
long primary apical dendrite, which next branches to
distal dendrites of a higher order [Fig. 4(B)]. To
quantitatively describe the morphology of the dendri-
tic trees, we calculated the TNDT, the total dendritic
length (TDL) and performed a Sholl analysis. As
shown in Figure 4(C,E), neurons with active Cre
recombinase exhibited a significant reduction of
TNDT of both basal and apical dendrites, as com-
pared with control. Moreover, the analysis of both
basal and apical dendrites showed a decrease in TDL
[Fig. 4(D,F)]. Thus, mTOR knockout significantly
decreased both the number and total length of den-
drites and shrunk both apical and basal dendritic
arbors.
Changes in dendritic arbor complexity were further
assessed using Sholl analysis separately for basal
[Fig. 4(G)] and apical [Fig. 4(H)] dendrites. The anal-
yses for both basal and apical parts of dendritic trees
showed the same significant radius effect (p< 0.001,
two-way repeated-measures ANOVA with interac-
tion), a significant reduction of the number of cross-
ings due to the mTOR knockout effect (p< 0.001;
two-way repeated-measures ANOVA with interac-
tion), and a significant interaction between radius and
the mTOR knockout effect (p< 0.001). Thus we con-
cluded that in both groups, the number of crossings
of basal and apical dendrites evolves with the radius.
In addition, the leftward and downward shift in the
knockout (Cre) profile plot is statistically significant,
as compared with control. Moreover, the comparison
(one-way ANOVA) of corresponding radii showed a
statistically significant difference in basal radii in the
30–90 mm range [Fig. 4(G)] and apical radii in the
20–150 mm range [Fig. 4(H)] from the center of
the cell soma. This data shows that knockout of
mTOR severely impairs complexity of both basal and
apical dendritic arbors.
mTOR is Needed for the Stabilization of
Basal Dendrites of Postnatally Born OB
Granular Neurons
In the experiments described above, mTOR was
inhibited in neuroblasts that migrated through the
RMS and consequently also in the early stages of
newly born neurons’ development in the OB. To
evaluate the role of mTOR during later stages of OB
neuron dendritic tree formation in vivo, we used
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systemic administration of the mTORC1 inhibitor
rapamycin in wildtype mice 10 days after electropora-
tion in an effort to target neurons after they reached
the OB and began dendritogenesis (Mizrahi, 2007).
We focus on mTORC1 for two reasons. First, intraper-
itoneal injections of rapamycin have been previously
extensively used to study mTOR in the brain. Second,
our results from different types of in vitro cultured
neurons suggested that mTORC1 may act downstream
of mTORC2 (Fig. 2 and Urbanska et al., 2012a).
Our previous results suggested that chronic ra-
pamycin treatment (4–6 weeks) in wildtype rodents
Figure 4 mTOR knockout affects postnatally born OB neuron dendritic arbors. (A) Diagram illus-
trating the design of the experiment. Mice were electroporated with pCAG-GFP, pCALNL-DsRed,
and pCAG (control) or pCAG-GFP, pCALNL-DsRed, and pCAG-Cre (experimental variant) on
P1-P2 and sacrificed after 14 dpe. (B) Representative three-dimensional reconstructions of GFP-
positive neurons after mTOR knockout vs. control in the olfactory bulb. Scale bar5 50 mm. (C, D)
Quantification of the total number of dendritic tips (TNDT, C) and total dendritic length (TDL, D)
of basal dendrites after mTOR knockout. (E, F) Quantification of the total number of dendritic tips
(TNDT, E) and total dendritic length (TDL, F) of apical dendrites after mTOR knockout. The
results are presented as a mean value6 SEM. Number of individual experiments5 4. Number of
animals (N)5 11 (control), 10 (Cre). Number of analyzed cells (n)5 89 (control), 49 (Cre).
***p< 0.001 (Mann–Whitney test). (G, H) Sholl analysis of basal and apical dendrites in OB neu-
rons. Significance for particular radii was assessed using one-way ANOVA. *p< 0.05, **p< 0.01,
***p< 0.001. For all graphs: number of individual experiments5 4; number of animals (N)5 11
(control), 10 (Cre); number of cells (n)5 89 (control), 49 (Cre). [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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can significantly affect the morphology of the brain
through the induction of hydrocephaly (Macias et al.,
2013). Thus, we first searched for the minimal dosage
of the drug that is required for mTOR inhibition in
the OB in neonates. Mouse neonates received either
two or three IP injections of rapamycin (1 mg/kg
rapamycin beginning on P8 or P10 at 48 h intervals)
or ethanol in vehicle solution, and protein lysates
were prepared from P14 mouse OBs to check for the
levels of P-S6 and P-Akt. Western blot analysis of
obtained protein lysates revealed a decrease in the
levels of P-S6 in the OB of rapamycin-treated mice
compared with vehicle-injected control animals.
Either two or three doses of rapamycin effectively
decreased P-S6 to a similar extent [Fig. 5(A)] without
causing gross changes in brain morphology (data not
shown). We also verified if such multiple rapamycin
injections affect mTORC2 activity in OB in vivo,
since it has been shown that prolonged exposure of in
vitro cultured neurons to rapamycin may affect both
complexes (Urbanska et al., 2012a). As shown in Fig-
ure 5(A), neither two nor three doses or rapamycin
significantly decreased phosphorylation of Ser473 of
Akt. In fact, slight increase in phosphorylation of
P-Akt was observed that is consistent with previous
observation that rapamycin may block negative feed-
back loops from mTOR to the receptor tyrosine
kinases. Therefore, two IP injections of the inhibitor
were used to block mTORC1 in subsequent experi-
ments focusing on neuronal morphology.
Next, P1–P2 wildtype mice were electroporated
with a GFP-encoding plasmid (pCx-EGFP-N1) and
treated with a total of two IP injections of rapamycin
at 10 and 12 dpe. The animals were sacrificed at 14
dpe, and OB sections were immunostained for GFP
followed by soma volume measurements and dendri-
tic arbor analysis. As shown in Figure 5(B), no sig-
nificant difference was found in soma volume
between rapamycin and control mice. The analysis of
dendritic trees, performed with three-dimensional
Figure 5.
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reconstructions of GFP-positive neurons in the OB
[Fig. 5(C)], revealed that in vivo rapamycin treatment
altered the TNDT and TDL of neurons in the OB.
But in contrast to Cre-mediated knockout, rapamycin
treatment specifically decreased the TNDT and TDL
of basal dendrites [Fig. 5(D,E)]. The TNDT and TDL
for apical dendrites did not differ significantly [Fig.
5(F,G)].
Finally, to more precisely analyze the pattern of
dendritic arborization and assess the coverage of
these dendritic fields, Sholl analysis was performed.
The number of crossings for the arborescence of a
single neuron at various radial distances from the cell
soma was tested. A two-way repeated-measure
ANOVA with interaction was used to analyze the
data for basal and apical arbors separately. The analy-
ses of basal dendrites [Fig. 5(H)] showed a significant
radius effect (p< 0.001), no significant reduction of
the number of crossings due to mTOR inhibition by
rapamycin (p5 0.0828), and no significant interac-
tion between radius and the rapamycin effect
(p< 0.369). Analysis of the number of crossings,
determined by the Sholl analysis, revealed small but
nonsignificant effects on basal branching. Compari-
sons of corresponding radii showed significant differ-
ences only for radii that were 70 mm from the cell
center.
For apical dendrites [Fig. 5(I)], the analysis
showed a significant radius effect (p< 0.001), no sig-
nificant reduction of the number of crossings due to
mTOR inhibition (p5 0.198), and no significant
interaction between radius and the rapamycin effect
(p5 0.933). For apical dendrites, the number of
crossings changed with the radius, but no changes
were observed in the complexity or the size of apical
dendrites in rapamycin-treated animals, as compared
with controls. In summary, rapamycin treatment led
to a small but significant decrease in the TNDT and
TDL of basal dendrites of neurons between
rapamycin-treated and control animals. The Sholl
analysis confirmed a trend toward basal dendritic
arbor simplification, but this effect did not reach sta-
tistical significance.
DISCUSSION
mTOR complexes were previously shown to modu-
late the dendritic arbor growth of different types of
embryonic neurons cultured in vitro (for review, see
Jaworski and Sheng, 2006; Swiech et al., 2008).
However, its involvement in in vivo dendritic arbor
development was studied almost exclusively under
conditions of hyperactivation of the mTORC1 signal-
ing pathway (Kwon et al., 2006; Chow et al., 2009;
Kim et al., 2009; Feliciano et al., 2012; Zhou et al.,
2013). Using in vitro cultures of differentiated SVZ-
derived neural progenitors and in vivo postnatal
Figure 5 Rapamycin treatment affects basal dendrites of postnatally born OB neurons. (A) West-
ern blot analysis of phosphorylated ribosomal protein S6 (P-S6, Ser235/236), total S6, phosphoryl-
ated Akt (P-Akt, Ser473) and total Akt levels in protein lysates obtained from olfactory bulbs from
animals treated with rapamycin (rapa) or vehicle solution (control). Mouse pups were treated with
two or three doses of 1 mg/kg rapamycin from 8 (3 doses) or 10 days (2 doses) after birth. Doses
were administered at 48 h intervals. Tubulin (Tub) was used as a loading control. (B) Quantitative
analysis of cell soma volume of GFP-positive neuronal cell body in olfactory bulb (OB). Mice were
electroporated with a GFP-encoding plasmid (pCx-EGFP-N1) on P1-P2, treated with 2 doses of
rapamycin or vehicle as described in A, and sacrificed at 14 dpe. All OB slices were immunostained
for GFP. Neuron cell somas were three-dimensionally reconstructed. The results are presented as a
mean value6 SEM. Number of animals (N)5 5 (control), 5 (rapa). Number of analyzed cells
(n)5 47 (control), 42 (rapa). ns, not significant (Mann-Whitney test). (C) Representative three-
dimensional reconstructions of GFP-positive neurons in olfactory bulb after IP injection of rapamy-
cin vs. control. Scale bar5 50 mm. Mice were electroporated with pCx-EGFP-N1 on P1-P2, intra-
peritoneally (IP) injected with two doses of rapamycin starting 10 dpe, and sacrificed at 14 dpe.
(D, E) Quantification of the total number of dendritic tips (TNDT, D) and total dendritic length
(TDL, E) of basal dendrites after IP rapamycin injections. (F, G) Quantification of the total number
of dendritic tips (TNDT, F) and total dendritic length (TDL, G) of apical dendrites after IP rapamycin
injections. The results are presented as a mean value6SEM. For all graphs: number of individual
experiments5 2; number of animals (N)5 5 (control), 5 (rapa); number of analyzed cells (n)5 52
(control), 57 (rapa). **p 0.01; ns, not significant (Mann–Whitney test). (H, I) Sholl analysis of
basal and apical dendrites in OB neurons. Significance for particular radii was assessed using one-
way ANOVA. For all graphs: number of individual experiments5 2; number of animals (N)5 5
(control), 5 (rapamycin); number of analyzed cells (n): 52 (control), 57 (rapamycin). *p 0.05.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
mTOR Regulates Dendritogenesis in Olfactory Bulb 15
Developmental Neurobiology
electroporation of cells in the SVZ, the present study
found that mTOR is indeed important for the dendri-
togenesis of postnatally born neurons both in vitro
and in vivo. Furthermore, the in vitro model revealed
that both mTOR complexes are important for
postnataly-born neuron development. In the in vivo
studies, we used two independent approaches to
silence mTOR during neurogenesis, including the dif-
ferentiation of postnatally born OB neurons. Each of
these approaches yielded slightly different results,
potentially revealing differences between mTOR
complexes during dendritogenesis and/or the larger
importance of mTOR signaling for basal dendritic
arbor development than for apical dendritic arbor
development and/or stability.
mTORCs Control the Formation
of Dendritic Arbors of Postnatally Born
Neurons Cultured In Vitro
In the in vitro experiments, we showed that the inhi-
bition of mTOR using rapamycin, both under stand-
ard culturing conditions and upon cell stimulation
with BDNF, prevented dendritic growth. This obser-
vation, although proving the importance of mTOR
for the proper dendritic arborization of neurons born
postnatally, is discordant with the observations of
Khodosevich and Monyer (2010). In a large high-
throughput screening of signaling pathways that are
involved in the neurite outgrowth of postnatally born
neurons, these authors suggested that rapamycin does
not affect this process. However, additional evidence
presented herein further supports an important role
for mTOR in the dendritic arbor formation of postna-
tally born neurons. First, treatment of postnatally
born neurons with Ku-0063794, a different mTOR
inhibitor, also led to simplification of dendritic arbors
of the analyzed neurons. Second, BDNF, a known
inducer of mTOR, induced the dendritic growth of
SVZ-born neurons. Third, a validated shRNA against
mTOR effectively blocked BDNF-induced dendrito-
genesis of these cells. Fourth, the removal of either
Rictor or Raptor yielded comparable results. The
major technical difference between the present study
and Khodosevich and Monyer (2010) is the doses of
rapamycin used in both studies. Khodosevich and
Monyer (2010) used rapamycin at a concentration of
50 pM. In the present study, we used 20 nM rapamy-
cin, which is one of the lowest doses that is efficiently
used in most long-term studies on dendritic arbor
development of neurons cultured in vitro (Jaworski
et al., 2005; Kumar et al., 2005). Therefore, we
believe that the dose of rapamycin that was used by
Khodosevich and Monyer (2010) was insufficient.
Our in vitro studies also provided information con-
cerning the potential mechanisms downstream of
mTOR that may be involved in the dendritic arbor
development of postnatally born neurons in response
to BDNF. We found that both mTOR complexes
(mTORC1 and mTORC2) are important for this pro-
cess and mTORC2 likely acts upstream mTORC1.
This observation is consistent with Urbanska et al.
(2012a), who showed that both complexes are needed
for basal and induced dendritic arborization in
embryonic hippocampal neurons. However, further
experiments are needed to determine the extent to
which the development of SVZ-derived neurons
mimics the development of embryonic hippocampal
neurons with regard to mTORC1 downstream effec-
tors (e.g., Cytoplasmic Linker Protein-170, Swiech
et al., 2011).
mTOR Controls the Morphology
of Postnatally Born Granule Neurons
In Vivo
In the next step of the present study, we evaluated
whether mTOR controls the morphology of dendritic
arbors of postnatally born OB neurons in vivo. We
used electroporation of NSCs in the SVZ in vivo and
focused on postnatally born granule cells (GCs)
because they form a relatively homogeneous group of
GABAergic neurons. The results demonstrated the
need for the presence of mTOR or its activity for the
proper development of dendritic arbors of postnatally
born GCs in the OB. Which regulators of dendrito-
genesis of postnatally born neurons act upstream
mTOR? At least three such factors, namely VEGF,
BDNF and GABA have been previously shown to
activate mTOR in different types of neurons (Takei
et al., 2004; Kim et al., 2008, 2009). However, thus
far only GABA, which acts as an excitatory neuro-
transmitter at early steps of neurogenesis, was proven
to indirectly, via increase in calcium influx, activate
mTOR during dendritogenesis of adult born neurons
in dentate gyrus of hippocampus in vivo (Kim et al.,
2009). Whether similar mechanism exist in OB neu-
rons needs to be established, but Gascon et al. (2006)
showed that GABA acts as an excitatory neurotrans-
mitter also on developing postnatally born OB neu-
rons to stabilize newly formed dendrites. Another
important regulator of mTOR-dependent dendrito-
genesis in hippocampal and cortical neurons is reelin
(Jossin and Goffinet, 2007; Matsuki et al., 2008).
Since reelin is also expressed in OB postnatally
(Hellwig et al., 2012) one could speculate that
reelin controls dendritogenesis of postnatally born
neurons in mTOR-dependent fashion. However, thus
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far, there is no evidence that reelin is needed for dendri-
tic arbor development in postnatally born OB neurons.
mTOR Knockout and Rapamycin
Treatment Differentially Affect the
Morphology of Postnatally Born Granule
Neurons In Vivo
The data presented herein suggest that although
mTOR is important for the growth of both basal and
apical dendrites during the initial steps of dendrito-
genesis, it may be selectively involved in the growth
and/or maintenance of basal dendrites at later stages
of this process. In the present study, mTOR activity
was modified in postnatally born OB neurons in two
different ways: (i) electroporation of NSCs in the
SVZ of Mtorfl/fl mice with constitutively active Cre
and (ii) IP injection of rapamycin in wildtype mice.
Methodological limitations did not allow us to
directly prove the effectiveness of mTOR knockout
in vivo. However, we provided evidence at the func-
tional level, showing that both approaches decreased
the level of the phosphorylated ribosomal S6 protein,
a commonly used marker of mTORC1 activity (Hart-
man et al., 2013; Lafourcade et al., 2013; Macias
et al., 2013). However, although both approaches
used herein relatively efficiently decreased the activ-
ity of mTOR in the brain in vivo, they differentially
affected dendritic morphology. Cre electroporation to
NSCs in the SVZ of Mtorfl/fl mice led to the simplifi-
cation of both apical and basal dendritic arbors of OB
neurons, whereas rapamycin affected only basal den-
dritic arbors. This difference may be related to the
scope and/or timing of mTOR inhibition as well as
population of cells, which experience mTOR
inhibition.
Rapamycin is a widely known inhibitor of mTOR,
but it does not equally affect all mTOR activities
(Dowling et al., 2010). Short-term rapamycin treat-
ment blocks, mTORC1 activity for some but not all
targets and does not affect mTORC2. Prolonged
treatment of in vitro cultured cells may affect a
broader array of mTORC1 effectors, but some may
remain insensitive to rapamycin treatment, depending
on cell type (Choo et al., 2008). Prolonged rapamycin
treatment of neurons cultured in vitro was shown to
decrease mTORC2 activity (Urbanska et al., 2012a).
These phenomena have not been comprehensively
studied in the mammalian brain in vivo. Data pre-
sented in Figure 5(A) show, that our protocol of rapa-
mycin application does not inhibit mTORC2 activity
in OB. In contrast, Cre-driven mTOR knockout
results in the loss of both mTORC1 and mTORC2
activity. Thus, differences in the mode of action of
our analytical tools (i.e., inhibition of a different set
of mTOR targets) could explain the different pheno-
types of apical dendrites of newly born OB neurons
in response to Cre knockout and rapamycin treat-
ment. Although we showed that mTORC1 acts down-
stream mTORC2, it is not a canonical effector of
mTORC2. In fact, mTORC2 is widely known for reg-
ulation of small GTPases of Rho family (Jacinto
et al., 2004), which are important regulators of actin
dynamics and dendritic growth (Urbanska et al.,
2008, 2012b). Thus, it is possible that canonical
mTORC2 effectors are important for apical dendrite
growth while mTORC1 is critical for basal dendritic
arbor development.
Another explanation of the observed differences,
not mutually exclusive with the above one, may
involve the timing of mTOR inhibition/knockout.
Based on our results, we can conclude that Cre electro-
poration of NSCs in the SVZ in Mtorfl/fl mice led to
mTOR knockout by 5 dpe (i.e., before neuroblasts
enter the OB at 9–10 dpe and start to grow den-
drites). Rapamycin was administered at 10 dpe (i.e.,
after the majority of neuroblasts enter the OB and
begin intensive dendritic arborization). Thus, using
different means of mTOR inhibition, we targeted early
(Cre-driven knockout) and late dendritogenesis. Con-
sequently, our results may be explained by the differ-
ential sensitivity of basal and apical dendrites to a lack
of mTOR (or more specifically mTORC1) at later
stages of development (i.e., during intensive remodel-
ing and the stabilization of dendritic arbors between
day 10 and 14) but not at earlier stages (before day
10). This possibility could be tested in the future with
use of inducible Cre-driven knockouts.
The apical and basal parts of dendritic trees are
functionally specialized and differentially regulated
(Cubelos et al., 2015). Little is known about the mech-
anisms that selectively maintain basal dendrites. One
example is a study that was performed on Epac2
(exchange protein directly activated by cAMP 2),
which helps regulate Rap, a Ras-like small GTPase,
that is highly enriched in the adult brain and dendrites
(Srivastava et al., 2012). Epac2 knockdown robustly
and selectively impaired basal dendrite maintenance in
cortical pyramidal neurons in vivo and in culture (Sri-
vastava et al., 2012). Another example was recently
published by Wu et al. (2015) who showed that stabil-
ity of basal dendrites of granular hippocampal neurons
relies specifically on extrinsic cues. In this context it is
worth noting that rapamycin, but not selective mTOR
KO, blocks mTORC1 activity not exclusively in post-
natally born neurons reaching OB but also in sur-
rounding cells, which serve as a source of extrinsic
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cues. Thus, mTORCs may participate in such specific
regulation of basal or apical maintenance.
Alternatively, one could speculate that apical and
basal dendritic arbors become stabilized at different
time points. At the time point at which we reached
sufficient mTOR inhibition, apical dendrites were rel-
atively stable, whereas basal dendrites were still
undergoing intensive remodeling. Mizrahi (2007)
showed that apical tufts of adult-born GCs were rela-
tively stable between 10 and 14 days after birth.
However, his observations were restricted only to
apical dendrites, and the level of basal dendrite sta-
bility remains unknown. The dynamics of the dendri-
tic arborization of neonatally born GCs also remains
to be determined. Therefore, further investigations
are needed to fully explain the differences in sensitiv-
ity between basal and apical dendrites of postnatally
born GCs to mTOR inhibition near the end of
dendritogenesis.
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